filmov
tv
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
Показать описание
Dr. Christopher M. Gallagher discusses real-world evidence supporting CDK4/6 inhibitor use in HR+ metastatic breast cancer.
MedEdOTG
Рекомендации по теме
0:04:48
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
1:02:43
Realizing the Potential of CDK 4/6 Inhibitor Therapy in Breast Cancer: Real-World Data and Evidence
1:06:57
Part 2 - Session 1 - CDK 4/6 Inhibitors in breast cancer: will they have a Large role in future?
0:07:06
Clinical insights into breast cancer trials | Matteo Lambertini
0:11:03
Dr Palanki Satya Dattatreya|Getting Real With Ribociclib Bridging the RCT and RWE universe with evid
0:19:40
Dr Rajat Bajaj | Consistently Superior Overall Survival with Kryxana
0:07:51
Real-world data and its real-world use
1:14:52
Novartis Sponsored Lecture
0:56:30
Harnessing the power of data science and real world evidence for cancer treatment, access and care
0:58:35
Genomics Pioneer, Cancer Survivor, Patient Advocate: Dr. Catalina Lopez-Correa, CSO of Genome Canada
2:44:17
Live Webinar - Breast cancer management 2022 & beyond || 21st Oct
0:22:04
Part 9 - Raising Standards in HR+ HER2- mBC management - Dr. Ajay Bapna
0:37:26
Palbociclib Combination in Advanced/mBC Real-World Evidence Speaker: Prof. Jean-Marc Nabholtz
1:11:25
Early breast cancer - OFS in premenopausal women – for whom and how long
0:25:55
ASU-ICOC 2020 - Session 31
2:40:24
Oncology Updates - 08 Jan 2025
2:02:26
I tumori con deficit dei meccanismi di riparazione attraverso ricombinazione omologa
2:45:26
Oncology Networks - 17 Dec 2024
2:02:05
Webinar Oncology Expert Sharing
2:12:01
Una ricerca diversa
0:04:48
1:02:43
1:06:57
0:07:06
0:11:03
0:19:40
0:07:51
1:14:52
0:56:30
0:58:35
2:44:17
0:22:04
0:37:26
1:11:25
0:25:55
2:40:24
2:02:26
2:45:26
2:02:05
2:12:01